These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21668315)

  • 1. The CD8 T-cell road to immunotherapy of toxoplasmosis.
    Bhadra R; Gigley JP; Khan IA
    Immunotherapy; 2011 Jun; 3(6):789-801. PubMed ID: 21668315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
    Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
    Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.
    Hwang S; Khan IA
    Semin Immunopathol; 2015 May; 37(3):271-9. PubMed ID: 25944514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii.
    Bhadra R; Guan H; Khan IA
    PLoS One; 2010 May; 5(5):e10842. PubMed ID: 20520779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells.
    Casciotti L; Ely KH; Williams ME; Khan IA
    Infect Immun; 2002 Feb; 70(2):434-43. PubMed ID: 11796568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune CD8(+) T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host.
    Khan IA; Green WR; Kasper LH; Green KA; Schwartzman JD
    Infect Immun; 1999 Nov; 67(11):5869-76. PubMed ID: 10531242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.
    Khan IA; Moretto M; Wei XQ; Williams M; Schwartzman JD; Liew FY
    J Exp Med; 2002 Jun; 195(11):1463-70. PubMed ID: 12045244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress of CD8+ T cell-mediated immune response to Toxoplasma gondii infection].
    Wu B; Lyu FL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Apr; 32(2):143-7. PubMed ID: 25065216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii.
    Saraav I; Wang Q; Brown KM; Sibley LD
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30814319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.
    Combe CL; Curiel TJ; Moretto MM; Khan IA
    Infect Immun; 2005 Aug; 73(8):4913-21. PubMed ID: 16041005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.
    Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Hassan IA; Xu L; Yan R; Song X; Li X
    BMC Infect Dis; 2015 Oct; 15():448. PubMed ID: 26497908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.
    Lieberman LA; Villegas EN; Hunter CA
    Infect Immun; 2004 Nov; 72(11):6729-32. PubMed ID: 15501812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice.
    Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Quan FS
    Korean J Parasitol; 2019 Oct; 57(5):543-547. PubMed ID: 31715698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Tsitsiklis A; Bangs DJ; Robey EA
    Trends Parasitol; 2019 Nov; 35(11):887-898. PubMed ID: 31601477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination.
    Guiton R; Zagani R; Dimier-Poisson I
    Parasite Immunol; 2009 Oct; 31(10):631-40. PubMed ID: 19751475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
    Gigley JP; Fox BA; Bzik DJ
    J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.
    Bhadra R; Gigley JP; Khan IA
    J Infect Dis; 2012 Jul; 206(1):125-34. PubMed ID: 22539813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite.
    Bhadra R; Khan IA
    Microbes Infect; 2012 Nov; 14(13):1160-8. PubMed ID: 22885140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
    Wilson DC; Matthews S; Yap GS
    J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
    Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
    Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.